{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:08:37Z","timestamp":1784740117395,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jaci.2012.05.032","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T21:46:41Z","timestamp":1340747201000},"page":"128-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: Early evidence supporting a paradigm shift in drug investigation?"],"prefix":"10.1016","volume":"130","author":[{"given":"Jonathan A.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.05.032_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62260-0","article-title":"Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system","volume":"87","author":"Day","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0091-6749(98)70172-1","article-title":"Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit","volume":"101","author":"Day","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1081-1206(10)63104-3","article-title":"Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis","volume":"79","author":"Day","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mai.2000.104550","article-title":"Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model","volume":"105","author":"Day","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1081-1206(10)63062-1","article-title":"Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit","volume":"79","author":"Day","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0091-6749(96)70257-9","article-title":"A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis","volume":"97","author":"Day","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1081-1206(10)63483-7","article-title":"Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure","volume":"77","author":"Donovan","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.anai.2010.01.012","article-title":"Factors that affect the allergic rhinitis response to ragweed allergen exposure","volume":"104","author":"Ellis","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1081-1206(10)61235-5","article-title":"Experimental models for the evaluation of treatment of allergic rhinitis","volume":"96","author":"Day","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2012.03.031","article-title":"Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes","volume":"130","author":"Jacobs","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaci.2010.09.043","article-title":"Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge","volume":"127","author":"Corren","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.05.032_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2500\/ajra.2010.24.3548","article-title":"Mometasone furoate nasal spray provides early, continuing relief of nasal congestion and improves nasal patency in allergic patients","volume":"24","author":"Salapatek","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2012.05.032_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1185\/030079904125003700","article-title":"A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit\u2014the Vienna Challenge Chamber (VCC)","volume":"20","author":"Stubner","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2012.05.032_bib14","unstructured":"Togias A. Asthma, Allergy, and Inflammation Branch, Division of Allergy, Immunology and Transplantation, NIAID\/NIH. Environmental exposure units: clinical trial design for validation. Bethesda: National Institute for Allergy and Infectious Diseases\/National Institutes of Health; 2010. p. 1-12."},{"key":"10.1016\/j.jaci.2012.05.032_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2500\/aap.2012.33.3579","article-title":"Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber","volume":"33","author":"Bernstein","year":"2012","journal-title":"Allergy Asthma Proc"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912008718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912008718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:31:37Z","timestamp":1758789097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912008718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0091674912008718"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.05.032","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: Early evidence supporting a paradigm shift in drug investigation?","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.03.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}